Clinical Trial of Recombinant Pneumococcal Protein Vaccine

Clinical trial NCT05622942 · COMPLETED

Trial details

NCT number: NCT05622942
Sponsor: CanSino Biologics Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pneumonia Respiratory Tract Diseases Respiratory Tract Infections

Start date: 2023-03-11
Primary completion: 2023-09-14
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.